HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Studies on novel bacterial translocase I inhibitors, A-500359s. II. Biological activities of A-500359 A, C, D and G.

Abstract
A-500359 A, C, D, G and capuramycin inhibited bacterial phospho-N-acetylmuramyl-pentapeptide-translocase (translocase I: EC 2.7.8.13) with IC50 values of 0.017, 0.12, 0.53, 0.14 and 0.018 microM, respectively. Consistently, A-500359 A, C and capuramycin inhibited in vitro peptidoglycan biosynthesis. A-500359 A exhibited reversible inhibition, which was mixed type and noncompetitive with respect to UDP-MurNAc-(N(epsilon)-Dns)pentapeptide (Ki=0.0079 microM) and undecaprenyl-phosphate, respectively. A-500359 A, C, D and G showed antimicrobial activity against Mycobacterium smegmatis. As a single intravenous injection of A-500359 A at a dose of 500 mg/kg showed no toxicity in mice, it was suggested that the capuramycin derivatives might become candidates as novel therapeutic agents for various diseases caused by Mycobacteria including tuberculosis.
AuthorsYasunori Muramatsu, Michiko Miyazawa Ishii, Masatoshi Inukai
JournalThe Journal of antibiotics (J Antibiot (Tokyo)) Vol. 56 Issue 3 Pg. 253-8 (Mar 2003) ISSN: 0021-8820 [Print] Japan
PMID12760681 (Publication Type: Journal Article)
Chemical References
  • Aminoglycosides
  • Anti-Bacterial Agents
  • Azepines
  • Enzyme Inhibitors
  • capuramycin
  • Transferases (Other Substituted Phosphate Groups)
  • phospho-N-acetylmuramoyl pentapeptide transferase
  • Uridine
Topics
  • Aminoglycosides
  • Animals
  • Anti-Bacterial Agents (chemistry, pharmacology, toxicity)
  • Azepines (chemistry, pharmacology, toxicity)
  • Bacteria (enzymology)
  • Enzyme Inhibitors (chemistry, pharmacology, toxicity)
  • Kinetics
  • Mice
  • Microbial Sensitivity Tests
  • Mycobacterium smegmatis (drug effects)
  • Transferases (Other Substituted Phosphate Groups)
  • Uridine (analogs & derivatives, chemistry, pharmacology, toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: